Delivery Order SPE2DB24D1205-SPE2DB24FCUMQ

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $1,287.80 firm-fixed-price contract is for the delivery of Lidocaine 5% Patches. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a large Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for Lidocaine 5% Patches, a specialty pharmaceutical product, with a ceiling value of $1,146.24 and a completion date of November 6, 2024. The contract has a firm fixed price pricing type and was not set aside for any specific business category. This delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,165.36, is for the supply of Lidocaine 5% patches to support federal healthcare programs and facilities. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $20,548.20 firm fixed-price contract is for the supply of Lidocaine 5% patches over a period ending on September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which Amerisourcebergen holds with the DLA Troop Support Medical to provide a wide range of medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,085.80 firm fixed-price contract is for the supply of Lidocaine 5% Patches. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Corporate Office division), a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patches with a total ceiling value of $19,182.58 and a period of performance through August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,812.28, is for the delivery of Lidocaine 5% Patches and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,687.05, is for the delivery of Lidocaine 5% Patches over the period ending on February 19, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,879.46, is for the delivery of Lidocaine 5% Patches. The contract has an ultimate completion date of December 9, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUMQ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $8,170.79 firm fixed-price contract is for the delivery of Lidocaine 5% patches. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/9/24, 2:08 PM